Journal article

Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function

L Atapattu, N Saha, C Llerena, ME Vail, AM Scott, DB Nikolov, M Lackmann, PW Janes

Journal of Cell Science | COMPANY BIOLOGISTS LTD | Published : 2012

Abstract

The ADAM10 transmembrane metalloprotease cleaves a variety of cell surface proteins that are important in disease, including ligands for receptor tyrosine kinases of the erbB and Eph families. ADAM10-mediated cleavage of ephrins, the ligands for Eph receptors, is suggested to control Eph/ephrin-mediated cell-cell adhesion and segregation, important during normal developmental processes, and implicated in tumour neo-angiogenesis and metastasis. We previously identified a substrate-binding pocket in the ADAM10 C domain that binds the EphA/ephrin-A complex thereby regulating ephrin cleavage. We have now generated monoclonal antibodies specifically recognising this region of ADAM10, which inhibi..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institute of Neurological Disorders and Stroke


Funding Acknowledgements

This work was supported by the National Health and Medical Research Council of Australia [grant numbers 384242 to M.L., P.W.J. and D.B.N., 487922 to M.L., and R.D. Wright, and Senior Research Fellowships to P.W.J. (334085) and M.L. (384113)]. Operational Infrastructure funding from the Victorian Government [to A.M.S.]; National Institutes of Health [grant number NS38486 to D.B.N.]; and the New York State Spinal Cord Injury research program [grant number C-022047 to N.S.].